Our offering includes novel formulation and processing solutions for biotherapeutic molecules. We have a wide range of comprehensive tools that improve process understanding and performance, increase target product quality, and reduce operating costs. These services capitalize on major investments in spray-drying facilities — including facilities capable of handling vaccines and molecules that pose moderate potential biosafety hazards — and state-of-the-art cell-culture research facilities featuring recent innovations in process design and process analytical technology (PAT).
Our suite of technologies and services include:
Stable vaccines with long shelf lives and reduced dependency on the cold chain are ideal for stockpiling and rapid deployment during public emergencies, including pandemics. Spray drying is a low-cost process that has potential to produce vaccines stable at a wide range of temperatures.